Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. [electronic resource]
Producer: 20090818Description: 2412-24 p. digitalISSN:- 1530-6860
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Biological Transport, Active -- drug effects
- Cell Degranulation -- drug effects
- Cell Membrane -- drug effects
- Chemokines -- metabolism
- Chemotaxis, Leukocyte -- drug effects
- Complement C5a -- administration & dosage
- Cytokines -- metabolism
- Disease Models, Animal
- Enzyme Inhibitors -- pharmacology
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Humans
- In Vitro Techniques
- Inflammation -- enzymology
- Male
- Mice
- Mice, Inbred BALB C
- NF-kappa B -- metabolism
- Neutrophils -- drug effects
- Peritonitis -- etiology
- Phospholipase D -- antagonists & inhibitors
- Phosphotransferases (Alcohol Group Acceptor) -- antagonists & inhibitors
- Respiratory Burst -- drug effects
- Resveratrol
- Stilbenes -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.